Middle East & Africa Diltiazem Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Capsules, Injection, and Tablets) and Application (Angina, Hypertension, and Others)
Market Introduction
Diltiazem is a benzothiazepine derivative that acts as an antihypertensive and vasodilator. Diltiazem is an antihypertensive and vasodilator that lowers blood pressure by relaxing the vascular muscle. This is due to the long-term therapeutic effects of decreasing blood pressure since it lowers the risk of fatal and non-fatal cardiovascular events, such as strokes and myocardial infarction. According to in vitro binding experiments, diltiazem is 70%-80% bound to plasma proteins. At clinically relevant concentrations, around 40% of the medication is thought to attach to alpha-1-glycoprotein, whereas about 30% of the drug is thought to bind to albumin.
Get more information on this report :
Market Overview and Dynamics
The Middle East & Africa diltiazem market is expected to reach US$ 38.55 million by 2028 from US$ 18.68 million in 2021; it is estimated to grow at a CAGR of 10.9% from 2021 to 2028. Rise in government initiatives for promotion, increase in the prevalence of cardiovascular diseases (CVDs), and rise in the elderly population with heart diseases worldwide are expected to boost the market growth over the years. However, the side effects of Diltiazem on consumption are likely to impact the market's growth in the coming years negatively.
Heart diseases are primarily observed in older adults due to their weak immunity and other major health problems. According to the Global Ageing 2019 survey, the world's population of 65 and above totaled 703 million in 2019. The elderly demographic is expected to double to 1.5 billion people by 2050. This demographic is more susceptible to CVDs such as arrhythmias. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. Structural and functional changes in the cardiovascular system associated with aging are major causes of cardiovascular diseases. Therefore, the rising geriatric population worldwide is leading to an increase in the incidence of cardiovascular disease, bolstering the growth of the diltiazem market. Also, the diltiazem market is characterized by the presence of various small and big companies. The market players adopt new product launches, regional expansions, and product approvals to increase their market share. The players are investing in R&D to develop advanced technologies and gain significant revenue share in the Middle East. For instance, in March 2021, Glenmark Pharmaceuticals was granted competitive generic therapy (CGT) designation for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg; therefore, it is eligible for 180 days of CGT exclusivity upon commercial marketing. Thus, such recent developments are expected to act as a future trend in the diltiazem market.
The COVID-19 outbreak has shown substantial effects in the Middle East & Africa. The region has observed an increasing number of patients admitted to intensive care units (ICUs). A rising number of medications impose multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices and pharmaceuticals. Also, the number of cases with chronic conditions has increased, resulting in increased use of drugs to combat the virus. During the widespread COVID-19 pandemic, there have been worries about the potential of certain blood pressure medications such as angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-converting blockers (ARB). The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptors to facilitate entry into the host cell. Hence, this pandemic has enhanced the business operation of the various drug manufacturers operating in the diltiazem market in the region with relatively low impact.
Key Market Segments
Based on product, the Middle East & Africa diltiazem market is segmented into capsules, injection, and tablets. In 2021, the tablets segment held the largest share of the market. However, the capsules segment is expected to witness the fastest CAGR from 2021 to 2028.
Based on application, the Middle East & Africa diltiazem market is segmented into angina, hypertension, and others. In 2021, the hypertension segment held the largest share of the market. The angina segment is expected to grow at the fastest CAGR in the coming years.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Middle East and Africa diltiazem market are the Dubai Health Authority (DHA), Ministry of Health and Prevention (MoHAP) and World Health Organization (WHO).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa diltiazem market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East and Africa diltiazem market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa diltiazem market.
MIDDLE EAST AND AFRICA DILTIAZEM MARKET SEGMENTATION
By Product Type
- Tablet
- Capsules
- Injection
By Application
- Hypertension
- Angina
- Others
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Company Profiles
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd
- MYLAN N.V.
- Pfizer Inc.
- Sandoz (Novartis AG)
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals PLC
- Zydus Cadila
- Glenmark
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Diltiazem Market – By Product Type
1.3.2 Middle East and Africa Diltiazem Market – By Application
1.3.3 Middle East and Africa Diltiazem Market – By Country
2. Middle East and Africa Diltiazem Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Diltiazem Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa – PEST Analysis
4.3 Experts Opinion
5. Diltiazem Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Cardiovascular Disease Incidence
5.1.2 Increasing Elderly Population
5.2 Market Restraints
5.2.1 Side Effects of Diltiazem
5.3 Market Opportunities
5.3.1 Growth Opportunities in Developing Nations
5.4 Future Trends
5.4.1 Recent Developments in Market
5.5 Impact Analysis
6. Diltiazem Market –Middle East and Africa Analysis
6.1 Middle East and Africa Diltiazem Market Revenue Forecast and Analysis
7. Diltiazem Market Analysis and Forecasts to 2028 – Product Type
7.1 Overview
7.2 Diltiazem Market Share by Product Type 2021 & 2028 (%)
7.3 Capsules
7.3.1 Overview
7.3.2 Capsules Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Injection
7.4.1 Overview
7.4.2 Injection Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Tablets
7.5.1 Overview
7.5.2 Tablet Market Revenue and Forecast to 2028 (US$ Mn)
8. Diltiazem Market Analysis And Forecasts TO 2028 – Application
8.1 Overview
8.2 Diltiazem Market Share by Application 2021 & 2028 (%)
8.3 Angina
8.3.1 Overview
8.3.2 Angina Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Hypertension
8.4.1 Overview
8.4.2 Hypertension Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Others
8.5.1 Overview
8.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Diltiazem Market – Middle East and Africa Analysis
9.1 Middle East and Africa: Diltiazem Market
9.1.1 Overview
9.1.2 Middle East & Africa: Diltiazem Market - Revenue and Forecast to 2028 (US$ Million)
9.1.3 Middle East and Africa Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.4 Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5 Middle East and Africa: Diltiazem Market, by Country, 2021 & 2028 (%)
9.1.5.1 Saudi Arabia: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Saudi Arabia: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 Saudi Arabia Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.3 Saudi Arabia Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.2 UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 UAE Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.4 UAE Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.3 South Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 South Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 South Africa Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.3 South Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.4 Rest of Middle East and Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.1 Rest of Middle East and Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.2 Rest of Middle East and Africa Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.4.3 Rest of Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Diltiazem Market
10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11. Diltiazem Market–Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies In The Diltiazem Market
12. Company Profiles
12.1 Bausch Health Companies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Teva Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MYLAN N.V.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sandoz (Novartis AG)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sun Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Hikma Pharmaceuticals PLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Zydus Cadila
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Glenmark
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Athenex
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. South Africa Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 8. South Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of Middle East and Africa Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 11. Glossary of Terms, Diltiazem Market
LIST OF FIGURES
Figure 1. Diltiazem Market Segmentation
Figure 2. Diltiazem Market Segmentation, By Country
Figure 3. Middle East and Africa Diltiazem Market Overview
Figure 4. Tablets Held the Largest Share of the Product Segment in Diltiazem Market
Figure 5. Middle East and Africa Diltiazem Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 7. Diltiazem Market: Impact Analysis of Drivers and Restraints
Figure 8. Middle East and Africa Diltiazem Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Diltiazem Market Share by Product Type 2021 & 2028 (%)
Figure 10. Capsules Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Injection Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Tablet Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Diltiazem Market Share by Application 2021 & 2028 (%)
Figure 14. Angina Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Hypertension Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Middle East and Africa: Diltiazem Market, by Key Country – Revenue (2021) (USD Million)
Figure 18. Middle East & Africa Diltiazem Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Middle East and Africa: Diltiazem Market, by Country, 2021 & 2028 (%)
Figure 20. Saudi Arabia: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. South Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Rest of Middle East and Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd
- MYLAN N.V.
- Pfizer Inc.
- Sandoz (Novartis AG)
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals PLC
- Zydus Cadila
- Glenmark
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa diltiazem market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa diltiazem market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.